Dry Age Macular Degeneration Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Astellas Pharma, Iveric Bio, Apellis Pharma…

Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies ...

Schizophrenia Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Lundbeck, Intra-cellular Therapies, Sumitomo P…

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...
MM&M

Pipeline Report 2025: Late-stage programs set to reshape treatment

As we approach 2026,late-stage programs across key therapeutic areas are poised to reshape treatment paradigms. Driven by novel mechanisms, first-in-class targets and more convenient administration ...
MarketWatch

Global Oil and Gas Construction Project Insights Report 2025: Pipeline Spending to Average $531 Billion Annually During 2027-2029, Private Financing Dominates With 54.3% Share ...

The "Project Insight - Global Oil and Gas Construction Projects (Q3 2025)" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed analysis of oil and gas projects ...